Merck & Co.

Merck signed a multi-year deal with Google Cloud, worth up to about $1 billion, to roll out an agentic AI platform across R&D, manufacturing, commercial and corporate teams.

Partners: Google Cloud

MSD worked with the AWS Generative AI Innovation Center on a tool that turns plain-language questions into SQL queries against complex healthcare datasets.

Partners: AWS

Merck runs an in-house, secured generative AI workspace called GPTeal that gives employees access to several large language models. The CIDO described broad staff adoption in an interview.

Partners: OpenAI, Meta, Anthropic

Merck co-developed KERMT with NVIDIA, a deep-learning model trained on millions of molecules to predict compound properties for drug discovery.

Partners: NVIDIA

Merck and Mayo Clinic agreed that Merck will use Mayo Clinic Platform's de-identified multimodal clinical and genomic data to validate AI models, including virtual-cell work, for target identification and early development choices.

Partners: Mayo Clinic

Merck signed a deal worth up to $349 million under which Variational AI tunes its generative chemistry platform on Merck data to design small molecules for two Merck-chosen targets.

Partners: Variational AI

Merck says it applies AI in clinical development to pick trial sites and to match and keep patients in studies.

Merck's data science and RWE groups agreed to use Atropos Health's platform and services to generate real-world evidence faster.

Partners: Atropos Health

Merck provides its field sales representatives with a generative AI chatbot to support their customer work.

Merck reports embedding AI throughout its content process, from idea generation through medical, legal and regulatory review.

Merck uses generative AI to produce supply chain risk assessments when disruptive events occur, reporting a turnaround of less than half an hour.

MSD and AWS explored a retrieval-augmented generative AI approach to help investigators handle manufacturing deviations, keeping generation to lower-risk steps with human oversight.

Partners: AWS

With AWS and Accenture, Merck built a cloud inference pipeline (HawkAVI) that analyses large volumes of inspection-machine data from its manufacturing sites.

Partners: AWS, Accenture

Merck built an internal generative AI tool that drafts clinical study reports for human review, more than halving first-draft effort, and has submitted CSRs produced this way.